Design Therapeutics, Inc. ( DSGN) - Key Metrics
DSGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.32 | -$0.25 | -$0.25 |
| 2026Q1 | $0 | -$0.29 | -$0.27 | -$0.27 |
| 2025Q4 | $0 | -$0.28 | -$0.21 | -$0.21 |
| 2025Q3 | $0 | -$0.30 | -$0.20 | -$0.20 |
| 2025Q2 | $0 | -$0.34 | -$0.25 | -$0.26 |
DSGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.30 |
| 2026Q1 | 0% | -9.17 |
| 2025Q4 | 0% | -8.69 |
| 2025Q3 | 0% | -6.28 |
| 2025Q2 | 0% | -2.48 |
DSGN
Price: $14.83
52 week price:
Earnings Per Share: -1.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 301800
Market Capitalization: 914.9 million